We are developing ultra-high-resolution imaging products to capture cellular images of the retina. We have sold products worth $1M to the world's leading ophthalmic researchers. The current gold standard is histology, which significantly slows down the research. This platform could also be used for early-diagnostics of eye diseases. Our technology has been protected by many patents.